Pharmacogenetics in solid organ transplantation: current status and future directions.
about
Factors affecting the long-term response to tacrolimus in renal transplant patients: pharmacokinetic and pharmacogenetic approach.Expression of IMPDH mRNA after mycophenolate administration in male volunteers.Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patientsTacrolimus and 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors: An interaction study in CYP3A5 non-expressors, renal transplant recipients.The use of a DNA biobank linked to electronic medical records to characterize pharmacogenomic predictors of tacrolimus dose requirement in kidney transplant recipients.Cyclosporine: a review.Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients.CYP3A polymorphisms and immunosuppressive drugs in solid-organ transplantation.Influence of IL-18 and IL-10 Polymorphisms on Tacrolimus Elimination in Chinese Lung Transplant Patients.Influence of cyclosporine and everolimus on the main mycophenolate mofetil pharmacokinetic parameters: Cross-sectional study.Molecular diagnostics in transplantation.Biomarkers of over-immunosuppression.Genes and beans: pharmacogenomics of renal transplant.Comparison of tacrolimus and cyclosporin A in CYP3A5 expressing Chinese de novo kidney transplant recipients: a 2-year prospective study.Biomarkers and personalized therapy in chronic kidney diseases.Significant reduction of Tacrolimus trough level after conversion from twice daily Prograf to once daily Advagraf in Chinese renal transplant recipients with or without concomitant diltiazem treatment.Impact of CYP3A5 genotype on tacrolimus versus midazolam clearance in renal transplant recipients: new insights in CYP3A5-mediated drug metabolism.Gastrointestinal Motility, Mucosal Mast Cell, and Intestinal Histology in Rats: Effect of Prednisone.In vivo CYP3A4 activity, CYP3A5 genotype, and hematocrit predict tacrolimus dose requirements and clearance in renal transplant patients.The interactions of age, sex, body mass index, genetics, and steroid weight-based doses on tacrolimus dosing requirement after adult kidney transplantation.The CYP3A4*22 C>T single nucleotide polymorphism is associated with reduced midazolam and tacrolimus clearance in stable renal allograft recipients.Individualization of tacrolimus dosage basing on cytochrome P450 3A5 polymorphism--a prospective, randomized, controlled study.Donors FMO3 polymorphisms affect tacrolimus elimination in Chinese liver transplant patients.Dynamic effects of CYP3A5 polymorphism on dose requirement and trough concentration of tacrolimus in renal transplant recipients.
P2860
Q33849108-BCA179DB-EE03-45E5-BA29-A39F037A500EQ33912025-0D0B2F86-2AF1-43FC-90E2-A8424E095DF3Q34065305-46CEFEBD-11E5-4524-B09D-62778E7A9543Q35157102-C4829F51-C9C2-4579-A3BB-D51023031EE3Q35612903-4182DEFB-D437-4D8C-858A-D1C48FEE71D1Q35675934-43E39AE4-EF88-4524-B081-F587270BA568Q36465101-7DB1FF2D-9905-4BF3-A81B-42AA01121520Q37478703-A06069AC-D4FC-4AB0-A4C2-4C7D25EAB901Q37633166-8E16E206-A9E3-4A6C-8117-F678366A01E0Q37737279-57476DBE-2375-4A4C-A3BA-3F2BD2892642Q37782254-F13A2600-1D11-4F17-86D5-74BA2A4CB727Q37895908-7CD36734-1DFB-499F-BDE0-07FE7FD3A7B4Q38104742-6E214524-F3FC-44BB-9F3E-EAAD7A5ED581Q41107159-F2BB9C61-34BE-4B71-94B4-671B8E684E88Q42662118-250F68C4-788A-4D5E-861A-5A01182891D4Q43941042-B192703A-1E1E-46AE-A52E-798A8F8E8057Q45279289-1560884E-70FA-4366-A54A-4AD9E966B964Q46036841-2CE1C822-26BF-4324-9893-DA0BA5D4D57AQ47292609-2042E695-6E64-4CEE-9094-33AE815B5D6FQ47342870-B4F7AB82-E665-41E8-905E-16F2B3646E92Q47803890-0B048859-8E93-4BA4-8559-2AC4B37B7931Q48088487-70B63898-0ED4-403E-B7F4-9E0A18BEB513Q50462011-93D2A739-77DD-41BD-88F2-73553419864DQ51045317-E6AA63C0-2A07-4766-B44E-5DC4AF98A1F6
P2860
Pharmacogenetics in solid organ transplantation: current status and future directions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacogenetics in solid organ transplantation: current status and future directions.
@en
Pharmacogenetics in solid organ transplantation: current status and future directions.
@nl
type
label
Pharmacogenetics in solid organ transplantation: current status and future directions.
@en
Pharmacogenetics in solid organ transplantation: current status and future directions.
@nl
prefLabel
Pharmacogenetics in solid organ transplantation: current status and future directions.
@en
Pharmacogenetics in solid organ transplantation: current status and future directions.
@nl
P1476
Pharmacogenetics in solid organ transplantation: current status and future directions.
@en
P2093
Dirk R J Kuypers
Hylke de Jonge
P356
10.1016/J.TRRE.2007.09.002
P577
2008-01-01T00:00:00Z